EUVIMEDEUVIMED entdecken
Open Access

The role of CNBP in brain atrophy and its targeting in myotonic dystrophy type 2

Katherine Jennings, Diana Lindquist, Ankita Poonia, Benedikt Schoser, Christiane Schneider-Gold, Nikolai A Timchenko, Lubov Timchenko

Human Molecular Genetics · 2025

DOI: 10.1093/hmg/ddaf002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Katherine Jennings und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Cincinnati Children's Hospital, 3333 Burnet Ave, Cincinnati, OH 45229, United States. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Brain, Myotonic Dystrophy. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NINDS NIH HHS, Cincinnati Children's Hospital Research Development Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myotonic Dystrophy type 2 (DM2) is a multisystem disease affecting many tissues, including skeletal muscle, heart, and brain. DM2 is caused by unstable expansion of CCTG repeats in an intron 1 of a gene coding for cellular nuclear binding protein (CNBP). The expanded CCTG repeats cause DM2 pathology due to the accumulation of RNA CCUG repeats, which affect RNA processing in patients’ cells. We have previously shown that mutant CCUG repeats reduce CNBP protein in DM2 patients. Reducing Cnbp in Cnbp KO mouse model causes late skeletal muscle atrophy. In this study, we examined if the reduction of Cnbp affects the Central Nervous System (CNS). MRI and DTI analyses showed that total brain volume and grey matter are reduced in Cnbp KO mice, while mean, radial and axonal brain diffusivity is increased. The morphological changes in the brains of Cnbp KO mice are accompanied by reduced stereotypic behavior, anxiety and neuromotor defects. These findings suggest that the reduction of CNBP contributes to CNS pathology in DM2. Since CNBP stability is regulated by pAMPK-dependent phosphorylation, we examined protein levels of pAMPK in DM2 cells and found that the active pAMPK is reduced in DM2. Interaction of CNBP with pAMPK and stability of CNBP protein are also decreased in DM2. Our data show that a small molecule AMPK activator A769662 corrects CNBP stability and normalizes CNBP targets in DM2 fibroblasts. Thus, activators of AMPK could potentially be developed as therapeutics to correct CNBP and reduce muscle and brain atrophies in DM2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA-Binding ProteinsBrainMyotonic DystrophyAnimalsMiceMice, KnockoutHumansDisease Models, AnimalAtrophyAMP-Activated Protein KinasesMuscle, SkeletalMale

Stichwörter der Autor:innen

AMPK activatorCNBPMyotonic Dystrophy type 2brain atrophy

Substanzen

RNA-Binding ProteinsAMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Division of Neurology, Cincinnati Children's Hospital, 3333 Burnet Ave, Cincinnati, OH 45229, United States.
  • Imaging Research Center, Cincinnati Children's Hospital, 3333 Burnet Ave, Cincinnati, OH 45229, United States.
  • Departments of Radiology, University of Cincinnati, 2600 Clifton Ave, Cincinnati, OH 45221, United States.
  • Pediatrics, University of Cincinnati, 2600 Clifton Ave, Cincinnati, OH 45221, United States.
  • Department of Neurology, Friedrich-Baur-Institute, LMU Clinics, Ziemssenstr, 1 Munich 80336, Germany.
  • Department of Neurology, St. Josef Hospital, Ruhr-University Bochum, Gudrinstr. 56, Bochum 44791, Germany.

Förderung

  • NIAMS NIH HHS
  • NINDS NIH HHS
  • Cincinnati Children's Hospital Research Development Funds
  • National Institute of Health
  • Cincinnati Children’s Hospital Research Development Funds
  • NIH

Zitieren

APA

Jennings, K., Lindquist, D., Poonia, A., Schoser, B., Schneider-Gold, C., Timchenko, N. A., & Timchenko, L. (2025). The role of CNBP in brain atrophy and its targeting in myotonic dystrophy type 2. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf002

Vancouver

Jennings K, Lindquist D, Poonia A, Schoser B, Schneider-Gold C, Timchenko NA, et al. The role of CNBP in brain atrophy and its targeting in myotonic dystrophy type 2. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf002

BibTeX
@article{Jennings2025,
  author = {Jennings, Katherine and Lindquist, Diana and Poonia, Ankita and Schoser, Benedikt and Schneider-Gold, Christiane and Timchenko, Nikolai A and Timchenko, Lubov},
  title = {The role of CNBP in brain atrophy and its targeting in myotonic dystrophy type 2},
  journal = {Human Molecular Genetics},
  year = {2025},
  doi = {10.1093/hmg/ddaf002}
}
Kostenlos starten →